IFM Investors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,219
| Closed | -$784K | – | 627 |
|
2025
Q1 | $784K | Hold |
3,219
| – | – | 0.01% | 582 |
|
2024
Q4 | $1.06M | Sell |
3,219
-226
| -7% | -$74.2K | 0.01% | 586 |
|
2024
Q3 | $1.15M | Sell |
3,445
-383
| -10% | -$128K | 0.01% | 583 |
|
2024
Q2 | $1.05M | Sell |
3,828
-229
| -6% | -$62.5K | 0.01% | 593 |
|
2024
Q1 | $1.4M | Buy |
+4,057
| New | +$1.4M | 0.02% | 570 |
|
2023
Q4 | – | Sell |
-4,057
| Closed | -$1.45M | – | 579 |
|
2023
Q3 | $1.45M | Buy |
4,057
+200
| +5% | +$71.7K | 0.02% | 564 |
|
2023
Q2 | $1.46M | Buy |
3,857
+80
| +2% | +$30.3K | 0.02% | 562 |
|
2023
Q1 | $1.81M | Buy |
3,777
+180
| +5% | +$86.2K | 0.03% | 507 |
|
2022
Q4 | $1.51M | Hold |
3,597
| – | – | 0.03% | 522 |
|
2022
Q3 | $1.5M | Hold |
3,597
| – | – | 0.03% | 514 |
|
2022
Q2 | $1.78M | Buy |
3,597
+239
| +7% | +$118K | 0.03% | 489 |
|
2022
Q1 | $1.89M | Buy |
3,358
+391
| +13% | +$220K | 0.03% | 500 |
|
2021
Q4 | $2.24M | Sell |
2,967
-80
| -3% | -$60.5K | 0.04% | 423 |
|
2021
Q3 | $2.27M | Buy |
3,047
+139
| +5% | +$104K | 0.05% | 399 |
|
2021
Q2 | $1.87M | Buy |
2,908
+608
| +26% | +$392K | 0.04% | 465 |
|
2021
Q1 | $1.31M | Buy |
2,300
+142
| +7% | +$81.1K | 0.04% | 476 |
|
2020
Q4 | $1.26M | Buy |
2,158
+325
| +18% | +$189K | 0.04% | 445 |
|
2020
Q3 | $945K | Buy |
1,833
+269
| +17% | +$139K | 0.04% | 413 |
|
2020
Q2 | $706K | Sell |
1,564
-57
| -4% | -$25.7K | 0.04% | 448 |
|
2020
Q1 | $566K | Buy |
1,621
+674
| +71% | +$235K | 0.03% | 503 |
|
2019
Q4 | $350K | Buy |
+947
| New | +$350K | 0.01% | 602 |
|